Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus A Wörns

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 16, 2010
Future perspectives in hepatocellular carcinomaMarcus A Wörns, Peter R Galle
Journal of Medical Case Reports|July 23, 2014
Combination therapy with silibinin, pegylated interferon and ribavirin in a patient with hepatitis C virus genotype 3 reinfection after liver transplantation: a case reportJohanna Knapstein, Marcus A Wörns, Peter R Galle, et al.
Visceral Medicine|July 15, 2016
Surveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver CirrhosisJens U Marquardt, Marc Nguyen-Tat, Peter R Galle, et al.
Oncology Research and Treatment|November 28, 2014
Treatment of malignant ascites with a second cycle of catumaxomab in gastric signet cell carcinoma--a report of 2 casesThomas Thomaidis, Marcus A Wörns, Peter R Galle, et al.
Journal of Hepatology|March 22, 2017
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapyPeter R Galle, Francesco Tovoli, Friedrich Foerster, et al.
Free Radical Biology & Medicine|March 13, 2012
The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytesJörn M Schattenberg, Marcus A Wörns, Tim Zimmermann, et al.
Deutsches Arzteblatt International|February 9, 2021
Tumor Incidence in Patients with Non-Alcoholic Fatty Liver DiseaseYvonne Huber, Christian Labenz, Maurice Michel, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 2, 2017
Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligationNadine Gehrke, Michael Nagel, Beate K Straub, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 27, 2016
Validation of Clinical Scoring Systems ART and ABCR after Transarterial Chemoembolization of Hepatocellular CarcinomaRoman Kloeckner, Michael B Pitton, Christoph Dueber, et al.
Health and Quality of Life Outcomes|January 15, 2020
Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relativesMichael Nagel, Christian Labenz, Marcus A Wörns, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 16, 2010
Future perspectives in hepatocellular carcinomaMarcus A Wörns, Peter R Galle
Journal of Medical Case Reports|July 23, 2014
Combination therapy with silibinin, pegylated interferon and ribavirin in a patient with hepatitis C virus genotype 3 reinfection after liver transplantation: a case reportJohanna Knapstein, Marcus A Wörns, Peter R Galle, et al.
Visceral Medicine|July 15, 2016
Surveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver CirrhosisJens U Marquardt, Marc Nguyen-Tat, Peter R Galle, et al.
Oncology Research and Treatment|November 28, 2014
Treatment of malignant ascites with a second cycle of catumaxomab in gastric signet cell carcinoma--a report of 2 casesThomas Thomaidis, Marcus A Wörns, Peter R Galle, et al.
Journal of Hepatology|March 22, 2017
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapyPeter R Galle, Francesco Tovoli, Friedrich Foerster, et al.
Free Radical Biology & Medicine|March 13, 2012
The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytesJörn M Schattenberg, Marcus A Wörns, Tim Zimmermann, et al.
Deutsches Arzteblatt International|February 9, 2021
Tumor Incidence in Patients with Non-Alcoholic Fatty Liver DiseaseYvonne Huber, Christian Labenz, Maurice Michel, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 2, 2017
Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligationNadine Gehrke, Michael Nagel, Beate K Straub, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 27, 2016
Validation of Clinical Scoring Systems ART and ABCR after Transarterial Chemoembolization of Hepatocellular CarcinomaRoman Kloeckner, Michael B Pitton, Christoph Dueber, et al.
Health and Quality of Life Outcomes|January 15, 2020
Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relativesMichael Nagel, Christian Labenz, Marcus A Wörns, et al.
Pageof 5